Literature DB >> 25549782

Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus.

Yulia Lakhman1, Derya Yakar, Debra A Goldman, Seth S Katz, Hebert A Vargas, Maura Miccò, Junting Zheng, Chaya S Moskowitz, Robert A Soslow, Hedvig Hricak, Nadeem R Abu-Rustum, Evis Sala.   

Abstract

PURPOSE: To develop a preoperative CT-based nomogram for predicting overall survival (OS) in patients with non-endometrioid carcinomas of the uterine corpus.
METHODS: Waiving informed consent, the institutional review board approved this HIPAA-compliant, retrospective study of 193 women with histopathologically proven uterine papillary serous carcinomas (UPSC), uterine clear cell carcinomas (UCCC), and uterine carcinosarcomas (UCS) who underwent primary surgical resection between May 1998 and December 2011, and had a preoperative CT ≤ 6 weeks before surgery. All CT scans were reviewed for local or/and regional tumor extent, presence of pelvic or/and para-aortic adenopathy, and presence of distant metastases. Univariate survival analysis was performed using log-rank test and Cox regression. Variables shown significant by the univariate analysis were evaluated with the multivariable Cox regression analysis and the results were used to create a nomogram for predicting OS. The predictive accuracy of the nomogram was assessed with the concordance probability index (c-index) and a 3-year calibration plot.
RESULTS: Mean patient age was 67.2 years (range 49.0-85.9); histologies included UPSC (n = 116), UCCC (n = 27), and UCS (n = 50). Median follow-up was 38.1 months (0.9-168.5 months). At multivariate analysis, patient age, ascites, and omental implants on CT were significant adverse predictors of OS and were used to build the nomogram. Concordance index for the nomogram was 0.640 ± 0.028.
CONCLUSION: We developed a nomogram with a good concordance probability at predicting OS based on readily available pretreatment clinical and imaging characteristics. This preoperative nomogram has the potential to improve initial treatment planning and patient counseling.

Entities:  

Mesh:

Year:  2015        PMID: 25549782      PMCID: PMC4965166          DOI: 10.1007/s00261-014-0337-0

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  17 in total

Review 1.  MRI of malignant neoplasms of the uterine corpus and cervix.

Authors:  Evis Sala; Suzanne Wakely; Emma Senior; David Lomas
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

2.  Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.

Authors:  Liang Wang; Hedvig Hricak; Michael W Kattan; Hui-Ni Chen; Peter T Scardino; Kentaro Kuroiwa
Journal:  Radiology       Date:  2005-12-12       Impact factor: 11.105

3.  External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer.

Authors:  Stephan Polterauer; Qin Zhou; Christoph Grimm; Veronika Seebacher; Alexander Reinthaller; Gerda Hofstetter; Nicole Concin; Mario M Leitao; Richard R Barakat; Nadeem R Abu-Rustum; Alexia Iasonos
Journal:  Gynecol Oncol       Date:  2012-03-23       Impact factor: 5.482

Review 4.  Endometrial cancer.

Authors:  Frederic Amant; Philippe Moerman; Patrick Neven; Dirk Timmerman; Erik Van Limbergen; Ignace Vergote
Journal:  Lancet       Date:  2005 Aug 6-12       Impact factor: 79.321

5.  Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables.

Authors:  M Hendrickson; J Ross; P J Eifel; R S Cox; A Martinez; R Kempson
Journal:  Gynecol Oncol       Date:  1982-06       Impact factor: 5.482

6.  The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.

Authors:  Sean Vance; Raphael Yechieli; Chad Cogan; Rabbie Hanna; Adnan Munkarah; Mohamed A Elshaikh
Journal:  Gynecol Oncol       Date:  2012-04-13       Impact factor: 5.482

7.  Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer.

Authors:  Michael W Kattan
Journal:  Curr Opin Urol       Date:  2003-03       Impact factor: 2.309

8.  Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system.

Authors:  Luigi Mariani; Rosalba Miceli; Michael W Kattan; Murray F Brennan; Maurizio Colecchia; Marco Fiore; Paolo G Casali; Alessandro Gronchi
Journal:  Cancer       Date:  2005-01-15       Impact factor: 6.860

9.  Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.

Authors:  Makoto Ohori; Michael W Kattan; Hideshige Koh; Norio Maru; Kevin M Slawin; Shahrokh Shariat; Masatoshi Muramoto; Victor E Reuter; Thomas M Wheeler; Peter T Scardino
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

10.  An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).

Authors:  Amanda Nickles Fader; David Starks; Paola A Gehrig; Angeles Alvarez Secord; Heidi E Frasure; David M O'Malley; Erin R Tuller; Peter G Rose; Laura J Havrilesky; Kathleen N Moore; Warner K Huh; Allison E Axtell; Joseph L Kelley; Kristine M Zanotti
Journal:  Gynecol Oncol       Date:  2009-08-26       Impact factor: 5.482

View more
  1 in total

Review 1.  Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta-analysis of survival.

Authors:  Antonio Raffone; Antonio Travaglino; Diego Raimondo; Manuela Maletta; Valentino De Vivo; Umberto Visiello; Paolo Casadio; Renato Seracchioli; Fulvio Zullo; Luigi Insabato; Antonio Mollo
Journal:  Int J Gynaecol Obstet       Date:  2021-12-11       Impact factor: 4.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.